Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk? ; volume:8 ; number:2 ; day:16 ; month:7 ; year:2019 ; pages:177-184 ; date:12.2019
Neurology and Therapy ; 8, Heft 2 (16.7.2019), 177-184, 12.2019
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Rivera, Victor M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-019-0145-0
- URN
-
urn:nbn:de:101:1-2020070114053166440666
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rivera, Victor M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radiologic Gastrostomy: An Unmet Need!
Biomarkers of sarcopenia: an unmet need
Uterine Fibroids: Burden and Unmet Medical Need
Personalised medicine, unmet need or business strategy?
What do oncologists need to know about biosimilar products?
Towards a New Understanding of Unmet Medical Need
Why We Don’t Need “Unmet Needs”! On the Concepts of Unmet Need and Severity in Health-Care Priority Setting
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
An unmet clinical need: roads to remyelination in MS
Animal models for large vessel vasculitis – The unmet need
Cost–related unmet need for healthcare services in Kenya
Radiologic Gastrostomy: An Unmet Need!
Biomarkers of sarcopenia: an unmet need
Uterine Fibroids: Burden and Unmet Medical Need
Personalised medicine, unmet need or business strategy?
What do oncologists need to know about biosimilar products?
Towards a New Understanding of Unmet Medical Need
Why We Don’t Need “Unmet Needs”! On the Concepts of Unmet Need and Severity in Health-Care Priority Setting
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
An unmet clinical need: roads to remyelination in MS
Animal models for large vessel vasculitis – The unmet need
Cost–related unmet need for healthcare services in Kenya
Radiologic Gastrostomy: An Unmet Need!
Biomarkers of sarcopenia: an unmet need
Uterine Fibroids: Burden and Unmet Medical Need
Personalised medicine, unmet need or business strategy?
What do oncologists need to know about biosimilar products?
Towards a New Understanding of Unmet Medical Need
Why We Don’t Need “Unmet Needs”! On the Concepts of Unmet Need and Severity in Health-Care Priority Setting
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
An unmet clinical need: roads to remyelination in MS
Animal models for large vessel vasculitis – The unmet need